Correlation Between Ocean Biomedical and Caribou Biosciences
Can any of the company-specific risk be diversified away by investing in both Ocean Biomedical and Caribou Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ocean Biomedical and Caribou Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ocean Biomedical and Caribou Biosciences, you can compare the effects of market volatilities on Ocean Biomedical and Caribou Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ocean Biomedical with a short position of Caribou Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ocean Biomedical and Caribou Biosciences.
Diversification Opportunities for Ocean Biomedical and Caribou Biosciences
0.02 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Ocean and Caribou is 0.02. Overlapping area represents the amount of risk that can be diversified away by holding Ocean Biomedical and Caribou Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Caribou Biosciences and Ocean Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ocean Biomedical are associated (or correlated) with Caribou Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Caribou Biosciences has no effect on the direction of Ocean Biomedical i.e., Ocean Biomedical and Caribou Biosciences go up and down completely randomly.
Pair Corralation between Ocean Biomedical and Caribou Biosciences
Given the investment horizon of 90 days Ocean Biomedical is expected to under-perform the Caribou Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Ocean Biomedical is 1.31 times less risky than Caribou Biosciences. The stock trades about -0.22 of its potential returns per unit of risk. The Caribou Biosciences is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 197.00 in Caribou Biosciences on September 30, 2024 and sell it today you would lose (30.00) from holding Caribou Biosciences or give up 15.23% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Insignificant |
Accuracy | 100.0% |
Values | Daily Returns |
Ocean Biomedical vs. Caribou Biosciences
Performance |
Timeline |
Ocean Biomedical |
Caribou Biosciences |
Ocean Biomedical and Caribou Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Ocean Biomedical and Caribou Biosciences
The main advantage of trading using opposite Ocean Biomedical and Caribou Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ocean Biomedical position performs unexpectedly, Caribou Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Caribou Biosciences will offset losses from the drop in Caribou Biosciences' long position.Ocean Biomedical vs. Enveric Biosciences | Ocean Biomedical vs. Hepion Pharmaceuticals | Ocean Biomedical vs. Elevation Oncology | Ocean Biomedical vs. Zura Bio Limited |
Caribou Biosciences vs. Intellia Therapeutics | Caribou Biosciences vs. Editas Medicine | Caribou Biosciences vs. Crispr Therapeutics AG | Caribou Biosciences vs. Verve Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.
Other Complementary Tools
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |